Lianying Medical announced that since 2026, the company has obtained a number of domestic and foreign medical device registration certificates, including the domestic NMPA color Doppler ultrasound diagnostic system, etc., the European Union CE positron transmitter and X-ray computed tomography scanning system, etc., and the US FDA's color Doppler ultrasound diagnostic system. As of June 30, product registration has covered more than 80 countries and regions around the world, and more than 160 models have been approved. 7 EU certifications and 20 FDA certifications were added during the reporting period. Obtaining a registration certificate is beneficial to diversifying product types and enhancing competitiveness, but the impact on revenue is not yet predictable.

Lianying Medical announced that since 2026, the company has obtained a number of domestic and foreign medical device registration certificates, including the domestic NMPA color Doppler ultrasound diagnostic system, etc., the European Union CE positron transmitter and X-ray computed tomography scanning system, etc., and the US FDA's color Doppler ultrasound diagnostic system. As of June 30, product registration has covered more than 80 countries and regions around the world, and more than 160 models have been approved. 7 EU certifications and 20 FDA certifications were added during the reporting period. Obtaining a registration certificate is beneficial to diversifying product types and enhancing competitiveness, but the impact on revenue is not yet predictable.